Posted in | News | Nanomedicine

New Insight Into Nanoassemblies for Specific Cancer Therapy

Although retinoic acid (RA) can induce cell death, its weak anticancer efficacy limits its clinical applications. To this end, stimulus-responsive self-assembling prodrug-based nanomedicines are promising candidates that enable controlled drug delivery. 

New Insight Into Nanoassemblies for Specific Cancer Therapy​​​​​​​

​​​​​​​Study: Self-deliverable and self-immolative prodrug nanoassemblies as tumor targeted nanomedicine with triple cooperative anticancer actions. Image Credit: Kateryna Kon/

In an article published in the journal Biomaterials, unique chemistry was explored to maximize the therapeutic potential of RA, wherein aryl boronic acid was subjected to hydrogen peroxide (H2O2) to release quinone methide (QM). Furthermore, the generation of hydroxy benzyl alcohol (HBA) from alkylates glutathione (GSH) suppressed the expression of vascular endothelial growth factor (VEGF).

The boronated RA prodrug (RABA) was formulated into robust drug delivery systems that are self-deliverable nanoassemblies that released QM and RA via H2O2-triggered self-immolation manner to exhibit anticancer activities. Moreover, RABA nanoassemblies promoted apoptosis of cancer cell-mediated by reactive oxygen species (ROS). 

The self-assembling prodrug-based drug delivery is beneficial for the excellent anticancer efficacy of RABA nanoassemblies. This strategy has provided new insight into the designing and development of self-immolating prodrug nanoassemblies for target-specific cancer therapy.

Prodrug Nanoassemblies as Drug Delivery Systems

Drug self-delivery based on nanoassemblies is a new paradigm for controlled drug delivery and efficient anticancer therapy. Moreover, this type of drug delivery allows intracellular delivery of drugs without the need for carriers, thus exhibiting nanoscale characteristics.

Molecular nanoassemblies involve an instantaneous assembling of small molecules to form well-organized nanostructures, while various noncovalent interactions are leveraged. Prodrugs are converted into active ingredients upon administration and enhance their therapeutic activity. Thus, prodrug delivery based on nanoassemblies involves modulation of the prodrug’s molecular structure to integrate them with molecular nanoassemblies enabling the formation of robust drug delivery systems.

These nanoassemblies are amphiphilic, possessing both hydrophilic and hydrophobic moieties, facilitating instantaneous assembly under aqueous conditions. Furthermore, the prodrug nanoassemblies formed enable controlled drug delivery.

RA plays a vital role in cell growth and differentiation and induces cancer cell apoptosis via cytotoxic activities. Moreover, RA is anticipated to enhance the efficacy of immune checkpoint inhibitors and antiangiogenic therapies. However, RA is inefficient in inducing cancer cell apoptosis compared to traditional anticancer drugs.

ROS such as H2O2 serves as a messenger in signaling pathways enabling tumor development. However, its excess presence induces damage to cancer cells leading to cell death. To this end, GSH is an antioxidant found in cells whose excess presence promotes tumor progression inducing therapeutic resistance to cancer cells.

Prodrug Nanoassemblies as Efficient Drug Delivery Systems

Boronic/boronated groups release the parent drug via an H2O2-triggered manner. Hence are used as a masking moiety for drugs in drug delivery. Aryl boronic/boronated groups connected to drug moieties via self-immolating spacer are oxidized in the presence of H2O2 to form QM through 1,6-elimination.

In the present work, the RABA hybrid prodrug was prepared based on self-immolating chemistry. Under H2O2 endogenous stimulus, the hybrid prodrug released pharmacologically active molecules (RA and QM). Furthermore, due to its amphiphilicity, RABA underwent self-assembly to form nanoassemblies in aqueous media, leading to a robust drug delivery system.

Since γ poly-glutamic acid (γ-PGA) was previously reported to bind to gamma-glutamyl transferase (GGT) with a high affinity, the RABA was coated with γ-PGA leading to tRABA nanoassemblies as drug delivery systems, employed as cancer-targeted nanomedicines. The synthesized tRABA nanoassemblies had a negative surface charge of -31 millivolts at pH 7.

Scanning electron microscope (SEM) results revealed that tRABA nanoassemblies were in the form of round spherical colloids with a mean hydrodynamic diameter of approximately 170 nanometers and polydispersity index (PDI) of 0.15. The tRABA nanoassemblies as efficient drug delivery systems showed excellent colloidal stability in the physiological solution, and superficial γ-PGA coating prevented protein adsorption on the tRABA nanoassemblies and aggregation.

The drug delivery and therapeutic actions of these tRABA nanoassemblies were triggered by endogenously produced H2O2. The therapeutic activity and translational potential of tRABA nanoassemblies were extensively investigated using mouse xenograft models and cell culture.

The results confirmed that the present work is a facile and highly efficient method to prepare hybrid prodrugs for their formulation into self-deliverable and self-immolating nanoassemblies as efficient drug delivery systems to exhibit synergistic anticancer actions and simultaneously overcome the limitations of carriers-mediated drug delivery.


To summarize, a self-deliverable and self-immolating drug delivery system, RABA was synthesized via a conjugation reaction between aryl boronic acid and RA. Self-assembly of RABA followed by coating with γ PGA resulted in γ PGA-coated RABA (tRABA) nanoassemblies, which released RA and QM in an H2O2-triggered manner inducing cancer cell apoptosis.

Furthermore, tRABA nanoassemblies targeted specific cancer cells that express gamma-glutamyl transferase (GGT). The in vivo studies on animal models demonstrated that the accumulation of tRABA nanoassemblies was specific to GGT expressing cancer cells that promoted the eradication of tumors.

The simple conjugation between boronic acid and RA allowed the formation of self-deliverable and self-immolating nanoassemblies. It led to triple cooperative anticancer activity and improved therapeutic potency of RA. With the help of the present work, tRABA nanoassemblies were demonstrated as potential drug delivery systems.


Jung, E., Jeong, S. W., Lee, Y., Jeon, C., Shin, H., Song, N., Lee, Y et al. (2022). Self-deliverable and self-immolative prodrug nanoassemblies as tumor targeted nanomedicine with triple cooperative anticancer actions. Biomaterials.

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Bhavna Kaveti

Written by

Bhavna Kaveti

Bhavna Kaveti is a science writer based in Hyderabad, India. She has a Masters in Pharmaceutical Chemistry from Vellore Institute of Technology, India, and a Ph.D. in Organic and Medicinal Chemistry from Universidad de Guanajuato, Mexico. Her research work involved designing and synthesizing heterocycle-based bioactive molecules, where she had exposure to both multistep and multicomponent synthesis. During her doctoral studies, she worked on synthesizing various linked and fused heterocycle-based peptidomimetic molecules that are anticipated to have a bioactive potential for further functionalization. While working on her thesis and research papers, she explored her passion for scientific writing and communications.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Kaveti, Bhavna. (2022, July 26). New Insight Into Nanoassemblies for Specific Cancer Therapy. AZoNano. Retrieved on April 18, 2024 from

  • MLA

    Kaveti, Bhavna. "New Insight Into Nanoassemblies for Specific Cancer Therapy". AZoNano. 18 April 2024. <>.

  • Chicago

    Kaveti, Bhavna. "New Insight Into Nanoassemblies for Specific Cancer Therapy". AZoNano. (accessed April 18, 2024).

  • Harvard

    Kaveti, Bhavna. 2022. New Insight Into Nanoassemblies for Specific Cancer Therapy. AZoNano, viewed 18 April 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.